March 4, 2026
Bial and GSK sign licensing agreement for COPD and asthma medicines in Portugal
Bial and GSK have concluded an agreement for the exclusive promotion, distribution, and sale in Portugal of the medicines Elebrato Ellipta, Laventair Ellipta, Revinty Ellipta, Trelegy Ellipta, Anoro Ellipta, and Relvar Ellipta. These medicines are intended for the treatment of people with chronic obstructive pulmonary disease (COPD) and asthma.